Related Experiment Video
Updated: Mar 1, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
Correlation between NF-κB signal pathway-mediated caspase-4 activation and Kawasaki disease
Jing Tian1, Xinjiang An1, Ling Niu1
1Department of Cardiology, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221002, P.R. China.
Insights
Nuclear factor-kappa B (NF-κB) activation drives caspase-4 expression, leading to inflammatory cytokine release and endothelial cell injury in Kawasaki disease (KD). Inhibiting NF-κB reduces these effects, highlighting its critical role in KD pathogenesis.
Area of Science:
- Immunology
- Molecular Biology
- Cardiovascular Research
Background:
- Kawasaki disease (KD) is an acute febrile vasculitis affecting young children, characterized by inflammation of medium-sized arteries, particularly coronary arteries.
- The precise molecular mechanisms underlying KD-induced endothelial cell injury and inflammation remain incompletely understood.
- Nuclear factor-kappa B (NF-κB) signaling is implicated in inflammatory processes, but its specific role in KD pathogenesis, particularly concerning caspase-4 activation, requires elucidation.
Purpose of the Study:
- To investigate the role and mechanisms of NF-κB-mediated caspase-4 activation in inducing inflammatory cytokines during Kawasaki disease (KD).
- To examine the impact of NF-κB and caspase-4 on coronary artery endothelial cell (HCAEC) injury and apoptosis in KD.
- To determine the therapeutic potential of inhibiting NF-κB in mitigating KD-related cellular damage.
Main Methods:
- Peripheral blood mononuclear cells (PBMCs) from KD patients and healthy controls were cultured and stimulated.
- Tumor necrosis factor-alpha (TNF-α) levels were measured using ELISA.
- Human coronary artery endothelial cells (HCAECs) were treated with KD patient-derived PBMC supernatant to assess NF-κB p65 activation, caspase-4 expression, cytokine secretion (IL-6, IL-1β), and apoptosis via Western blot, immunofluorescence, ELISA, and Annexin V/PI staining.
- NF-κB inhibition was achieved using SN50.
Main Results:
- Stimulated PBMCs from KD patients exhibited significantly higher TNF-α secretion compared to controls.
- HCAECs treated with KD patient PBMC supernatant showed significantly elevated NF-κB p65 and caspase-4 expression, along with increased IL-6, IL-1β secretion, and apoptosis.
- NF-κB inhibition with SN50 significantly attenuated caspase-4 expression, inflammatory cytokine secretion, and HCAEC apoptosis.
Conclusions:
- NF-κB signaling pathway activation is crucial in Kawasaki disease.
- NF-κB induces inflammatory factors (IL-6, IL-1β) and mediates caspase-4 expression in HCAECs, contributing to endothelial cell apoptosis and injury.
- NF-κB-mediated caspase-4 expression plays a critical role in the pathogenesis of Kawasaki disease, representing a potential therapeutic target.
Abstract:
The aim of the study was to investigate the role and mechanisms of action of nuclear factor-κB (NF-κB)-mediated caspase-4 activation in the induction of inflammatory cytokines during Kawasaki disease (KD) and coronary artery endothelial cell injury. Peripheral blood mononuclear cells (PBMCs) were isolated from KD patients and healthy controls and cultured. Double antibody sandwich enzyme-linked immunosorbent assay (ELISA) was applied to detect tumor necrosis factor (TNF)-α levels in activated PBMC-conditioned culture media. To establish a culture model for human coronary artery endothelial cells (HCAECs), we employed KD patient-origin PBMC culture-conditioned media to induce HCAEC transformation and detected the nuclear activation of NF-κB p65 and intracellular caspase-4 protein concentrations using western blot analysis. We also investigated the nuclear transfer of NF-κB p65 using immunofluorescence, as well as HCAEC interleukin (IL)-6 and IL-1β secretion using ELISA. Finally, we investigated HCAEC apoptosis using using Annexin V/PI double staining. After PBMCs were stimulated in vitro, TNF-α secretion was significantly higher in the KD group versus controls (P<0.01). HCAEC cells treated with supernatant conditioned by cells from KD patients showed a significant elevation of NF-κB p65 and caspase-4 protein expression versus HCAEC cells treated with supernatant conditioned by control cells (P<0.01). Similarly, IL-6 and IL-1β secretion, as well as apoptotic rate, were significantly elevated (P<0.01). SN50, an NF-κB inhibitor, significantly attenuated caspase-4 expression, secretion of IL-6, IL-1β, and TNF-α, as well as HCAEC apoptosis in cells treated with KD patient PBMC-conditioned media. NF-κB can induce the generation of various inflammatory factors including IL-6 and IL-1β, mediate the expression of caspase-4 in HCAEC cells, and affect apoptosis and injury of HCAEC cells. Therefore, the expression of caspase-4, mediated by NF-κB signal pathway, plays a critical role in KD.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Caspases
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway

